Respiratory Investigation

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Respiratory Investigation is a journal published by Elsevier BV in Netherlands. It is listed in MEDLINE according to the sources read. Declared publication charge: 3,000 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
2212-5353 · 2212-5345
Country
Netherlands
Access
Not open access / not declared
Declared publication charge
3,000 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2012-01-01
Indexing
MEDLINE
APC
3,000 USD
Declared review time (DOAJ)
—
Actual review time (measured)
111 days received→accepted — computed from PubMed (n=97)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1516

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

53

i10-index

455

From OpenAlex open data (CC0).

Editorial & policy3
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Open references deposited at Crossref
97%
ORCID iDs in current deposits
95%
Deposits licence metadata at Crossref
✓
Identity & continuity3
Source type
journal
NLM unique ID (PubMed)
101581124
Society affiliations
The Japanese Respiratory Society
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Asthma and respiratory diseases
  • Lung Cancer Diagnosis and Treatment
Show all subjects (75)
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Asthma and respiratory diseases
  • Asthma and respiratory diseases
  • Occupational and environmental lung diseases
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Pulmonary Hypertension Research and Treatments
  • Respiratory Support and Mechanisms
  • Respiratory Support and Mechanisms
  • COVID-19 Clinical Research Studies
  • Lung Cancer Treatments and Mutations
  • Medical Imaging and Pathology Studies
  • Respiratory Support and Mechanisms
  • Respiratory and Cough-Related Research
  • Respiratory and Cough-Related Research
  • Pneumonia and Respiratory Infections
  • Tracheal and airway disorders
  • Tracheal and airway disorders
  • Pulmonary Hypertension Research and Treatments
  • Pulmonary Hypertension Research and Treatments
  • Systemic Sclerosis and Related Diseases
  • Systemic Sclerosis and Related Diseases
  • Transplantation: Methods and Outcomes
  • Pleural and Pulmonary Diseases
  • Pleural and Pulmonary Diseases
  • Systemic Sclerosis and Related Diseases
  • Pleural and Pulmonary Diseases
  • Pneumonia and Respiratory Infections
  • Pneumonia and Respiratory Infections
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Sarcoidosis and Beryllium Toxicity Research
  • Lung Cancer Research Studies
  • Sarcoidosis and Beryllium Toxicity Research
  • Tuberculosis Research and Epidemiology
  • Respiratory viral infections research
  • Respiratory viral infections research
  • Respiratory and Cough-Related Research
  • Mycobacterium research and diagnosis
  • SARS-CoV-2 and COVID-19 Research
  • Cystic Fibrosis Research Advances
  • Long-Term Effects of COVID-19
  • Long-Term Effects of COVID-19
  • Mycobacterium research and diagnosis
  • Mycobacterium research and diagnosis
  • Inflammatory Myopathies and Dermatomyositis
  • Tuberculosis Research and Epidemiology
  • Inflammatory Myopathies and Dermatomyositis
  • Tuberculosis Research and Epidemiology
  • Nosocomial Infections in ICU
  • Neonatal Respiratory Health Research
  • Nosocomial Infections in ICU
  • Neonatal Respiratory Health Research
  • Cystic Fibrosis Research Advances
  • Cystic Fibrosis Research Advances
  • Inhalation and Respiratory Drug Delivery
  • Inhalation and Respiratory Drug Delivery
  • Medical Imaging and Pathology Studies
  • Medical Imaging and Pathology Studies
  • Cancer Immunotherapy and Biomarkers
  • Airway Management and Intubation Techniques
  • Actinomycetales infections and treatment
  • Tracheal and airway disorders
  • Respiratory viral infections research

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: